Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,268 public trials 269 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions
Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 14 locations
View Trial Details
Completed

Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma

NCT03250325

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +4 more
Locations
  • Sapporo Medical University Hospital Sapporo, Hokkaido, Japan
  • Mie University Hospital Tsu, Mie-ken, Japan
  • National Hospital Organization Osaka National Hospital Osaka, Japan
  • National Cancer Center Hospital Chuo-ku, Tokyo, Japan
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

NCT03507491

Conditions
Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +33 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Chilldren's Healthcare of Atlanta Atlanta, Georgia, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
View Trial Details
Completed

EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

NCT02601937

Conditions
INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Neoplasms, +9 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California San Francisco - Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

Eribulin in Advanced Solitary Fibrous Tumor

NCT03840772

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +5 more
Locations
  • Azienda Ospedaliera Universitaria Paolo Giaccone Palermo, PA, Italy
  • Policlinico Universitario Campus Biomedico Roma, RM, Italy
  • Fondazione IRCCS INT Milano Milan, Italy
View Trial Details

Related conditions